fluorodeoxyglucose f18 has been researched along with azd 6244 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Altabef, A; Bardeesy, N; Butaney, M; Cameron, MD; Cantley, LC; Castrillon, DH; Chen, Z; Cheng, K; Chirieac, LR; Costa, DB; Demetri, GD; Ebi, H; Engelman, JA; Franchetti, Y; Gao, P; Hayes, DN; Jackman, D; Jänne, PA; Kung, AL; Lee, C; Lee, CB; Li, J; Liu, Y; Nakada, Y; Nishino, M; Ouyang, J; Pandolfi, PP; Peña, CG; Roberts, PJ; Saur, A; Sharpless, NE; Shimamura, T; Sun, Y; Tupper, T; Walton, Z; Wang, S; Wang, Y; Wilkerson, MD; Wong, KK; Woo, MS; Xu, C; Yanagita, M; Yao, C | 1 |
| Barjat, H; Emmas, SA; Honndorf, VS; Pichler, BJ; Quintanilla-Martinez, L; Schmidt, H; Stahlschmidt, A; Wehrl, HF; Wiehr, S | 1 |
| Butler, E; Geboers, S; Hao, G; Kim, J; Laetsch, TW; Nham, K; Schwettmann, B; Skapek, SX; Sun, X; Williams, NS; Xu, L | 1 |
3 other study(ies) available for fluorodeoxyglucose f18 and azd 6244
| Article | Year |
|---|---|
A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Biomarkers, Tumor; Clinical Trials, Phase II as Topic; Disease Models, Animal; Docetaxel; Drug Evaluation, Preclinical; Fluorodeoxyglucose F18; Genes, p53; Humans; Lung Neoplasms; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase Kinases; Mutation; Pharmacogenetics; Positron-Emission Tomography; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Randomized Controlled Trials as Topic; ras Proteins; Reproducibility of Results; Taxoids; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
The Synergistic Effect of Selumetinib/Docetaxel Combination Therapy Monitored by [(18)F]FDG/[(18)F]FLT PET and Diffusion-Weighted Magnetic Resonance Imaging in a Colorectal Tumor Xenograft Model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Cell Proliferation; Colorectal Neoplasms; Dideoxynucleosides; Diffusion Magnetic Resonance Imaging; Docetaxel; Drug Synergism; Fluorodeoxyglucose F18; HCT116 Cells; Humans; Immunohistochemistry; Mice; Positron-Emission Tomography; Taxoids; Xenograft Model Antitumor Assays | 2016 |
Functional imaging of RAS pathway targeting in malignant peripheral nerve sheath tumor cells and xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzimidazoles; Cell Proliferation; Fluorodeoxyglucose F18; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Neurofibrosarcoma; Positron Emission Tomography Computed Tomography; Pyridones; Pyrimidinones; Radiopharmaceuticals; ras Proteins; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2020 |